CLVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CLVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Clarivate's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $0 Mil.
Clarivate's annual Other Stockholders Equity stayed the same from Dec. 2021 ($-0 Mil) to Dec. 2022 ($-0 Mil) but then increased from Dec. 2022 ($-0 Mil) to Dec. 2023 ($0 Mil).
The historical data trend for Clarivate's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clarivate Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Clarivate Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity
Thank you for viewing the detailed overview of Clarivate's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael J Angelakis | director | 40 MORRIS AVENUE, BRYN MAWR PA 19010 |
Bar Veinstein | officer: President, A&G | 70 ST. MARY AXE, LONDON X0 EC3 8BA |
Saurabh Saha | director | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Andrew Miles Snyder | director | 111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019 |
Melanie Margolin | officer: Chief Legal Officer | 1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905 |
Henry Levy | officer: President, LS&H | 70 ST. MARY AXE, LONDON X0 EC3 8BA |
James Gordon Samson | officer: President, IP Group | FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ |
Wendell E. Pritchett | director | TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034 |
Jonathan Gear | director, officer: Chief Executive Officer-Elect | C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY |
Michael M Easton | officer: Senior VP, Finance/CAO | 4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY |
Stefano Maestri | officer: Chief Technology Officer | 70 ST MARY AXE, LONDON X0 EC3 8BA |
Jonathan Mark Collins | officer: Executive Vice President/CFO | 50196 VENICE COURT, NORTHVILLE MI 48168 |
Mukhtar Ahmed | officer: President, Science Group | FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ |
Heather Matzke-hamlin | officer: Acting Chief Acctg Officer | 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY |
Steen Lomholt-thomsen | officer: Chief Revenue Officer | FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ |
From GuruFocus
By PRNewswire • 09-23-2024
By PRNewswire • 11-12-2024
By PRNewswire • 10-16-2024
By PRNewswire • 10-04-2024
By PRNewswire • 11-27-2024
By GuruFocus News • 12-05-2024
By GuruFocus News • 11-07-2024
By PRNewswire • 11-06-2024
By PRNewswire • 09-18-2024
By PRNewswire • 08-20-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.